Pretreatment antiretroviral exposure from recreational use
Lancet Infect Dis
.
2013 Jan;13(1):10-2.
doi: 10.1016/S1473-3099(12)70294-3.
Authors
David J Grelotti
1
,
Elizabeth F Closson
,
Matthew J Mimiaga
Affiliation
1
Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA; Partners In Health, Boston, MA 02215, USA. dgrelotti@pih.org
PMID:
23257221
PMCID:
PMC4299817
DOI:
10.1016/S1473-3099(12)70294-3
No abstract available
MeSH terms
Anti-Retroviral Agents / administration & dosage*
Anti-Retroviral Agents / adverse effects*
Drug Resistance, Viral
HIV / drug effects*
HIV Infections / drug therapy*
HIV Infections / virology
Humans
Substances
Anti-Retroviral Agents
Grants and funding
T32 MH017119/MH/NIMH NIH HHS/United States